F. Michael Ball — CEO, Alcon at Novartis | Comparably
Michael Francis Land. 12 April 1942—14 December 2020 | Biographical Memoirs of Fellows of the Royal Society
Thomas Glanzmann - Director at Alcon | The Org
F. Michael Ball News & Articles | Crain's Chicago Business
F. Michael Ball Net Worth (2023) | wallmine
Alcon - Governance - Board of Directors
Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
Alcon - Governance - Board of Directors
17. Alcon (Novartis AG) | Medical Product Outsourcing
Alcon Announces Results of 2023 Annual General Meeting
Alcon - Governance - Board of Directors
An Investment Review of Alcon Inc. Since Its Spin-off from Novartis
Alcon becomes a separately traded standalone company | Novartis
Michael Ball | LinkedIn
F. Michael Ball — CEO, Alcon at Novartis | Comparably
Aerie raids Alcon again, returning this time with an R&D VP | Fierce Biotech
Novartis sees weak Q4 and year, and expects a 2017 repeat, putting Alcon's future in question | Fierce Pharma
Alcon's top executive is out as eye-care sales plummet | Fort Worth Star-Telegram
Meet Our Board - Ophthalmology Foundation
Alcon - Governance - Board of Directors
Spotlight On... Novartis' troubled Alcon unit recalls eye drops for sterility, potency problems; Endo tanks on women's health sale; AZ sells rights to constipation drug; Denmark vies for EMA; and more...
Mike Ball, Alcon Inc: Profile and Biography - Bloomberg Markets
Untitled
Alcon becomes a separately traded standalone company | Novartis
F. Michael Ball — CEO, Alcon at Novartis | Comparably
